Dabrafenib in the treatment of metastatic or unresectable melanoma

Leila Khoja
, David Hogg

Immunology and Immunotherapy

Research output: Contribution to journal › Review article › peer-review

5 Citations (Scopus)

Overview
Fingerprint

Fingerprint

Dive into the research topics of 'Dabrafenib in the treatment of metastatic or unresectable melanoma'. Together they form a unique fingerprint.

Sort by

Weight
Alphabetically

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Powered by Pure Link opens in a new tab, Scopus Link opens in a new tab & Elsevier Fingerprint Engine™ Link opens in a new tab

All content on this site: Copyright © 2026 University of Birmingham, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

University of Birmingham data protection policy Link opens in a new tab

About web accessibility Link opens in a new tab

Report vulnerability Link opens in a new tab